Mereo BioPharma Group plc

(NASDAQ:MREO) Trade

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Mereo BioPharma Group PLC is a multi-asset biopharmaceutical company. It is focused on the acquisition, development, and commercialization of innovative therapeutics to improve outcomes for patients with rare and specialty diseases. The company portfolio consists of clinical-stage product candidates that include BPS-804 (setrusumab), AZD-9668 (alvelestat), BGS-649 (leflutrozole), OMP-313M32 (etigilimab), OMP-305B83 (navicixizumab) and BCT-197 (acumapimod).

Contact Information

Website: www.mereobiopharma.com
Email: cs@mereobiopharma.com
Main Phone: +44 3330237300
Address: One Cavendish Place
Address 2: 4th Floor
City / Town: London
Country: GB
Postal Code: W1G 0QF

Issuer Information

Exchange: NSD
CEO: Denise Vera Scots-Knight
Employees: 50

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A